🇺🇸 FDA
Patent

US 10174041

Methods and compositions for inhibiting the interaction of menin with MLL proteins

granted A61PA61P3/10A61P35/00

Quick answer

US patent 10174041 (Methods and compositions for inhibiting the interaction of menin with MLL proteins) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P3/10, A61P35/00, A61P35/02, A61P35/04